Salivary biomarkers for cancer diagnosis: a meta-analysis

References

• Schiffman JD, Fisher PG, Gibbs P. Early detection of cancer: past, present, and future. Am Soc Clin Oncol Educ Book. 2015:57–65.
   PubMedGoogle Scholar
• Nair M, Sandhu SS, Sharma AK. Cancer molecular markers: a guide to cancer detection and management. Semin Cancer Biol. 2018;52:39–55.
   PubMed Web of Science ®Google Scholar
• Babayan A, Pantel K. Advances in liquid biopsy approaches for early detection and monitoring of cancer. Genome Med. 2018;10:21.
   PubMed Web of Science ®Google Scholar
• Domínguez-Vigil IG, Moreno-Martínez AK, Wang JY, et al. The dawn of the liquid biopsy in the fight against cancer. Oncotarget. 2018;9:2912–2922.
   PubMedGoogle Scholar
• Crowley E, Di Nicolantonio F, Loupakis F, et al. Liquid biopsy: monitoring cancer-genetics in the blood. Nat Rev Clin Oncol. 2013;10:472–484.
   PubMed Web of Science ®Google Scholar
• Bardelli A, Pantel K. Liquid biopsies, what we do not know (Yet). Cancer Cell. 2017;31:172–179
   PubMed Web of Science ®Google Scholar
• Rapado-González Ó, Majem B, Muinelo-Romay L, et al. Cancer salivary biomarkers for tumours distant to the oral cavity. Int J Mol Sci. 2016;17:1531.
   Web of Science ®Google Scholar
• Bonne NJ, Wong DT. Salivary biomarker development using genomic, proteomic and metabolomic approaches. Genome Med. 2012;4:82.
   PubMed Web of Science ®Google Scholar
• Yoshizawa JM, Schafer CA, Schafer JJ, et al. Salivary biomarkers: toward future clinical and diagnostic utilities. Clin Microbiol Rev. 2013;26:781–791.
   PubMed Web of Science ®Google Scholar
• Spielmann N, Wong DT. Saliva: diagnostics and therapeutic perspectives. Oral Dis. 2011;17:345–354.
   PubMed Web of Science ®Google Scholar
• Ai J, Smith B, Wong DT. Saliva ontology: an ontology-based framework for a salivaomics knowledge base. BMC Bioinformatics. 2010;11:302.
   PubMed Web of Science ®Google Scholar
• Rapado-González M, Álvarez-Castro DP, Abalo SC. A novel saliva-based miRNA signature for colorectal cancer diagnosis. J Clin Med. 2019;8:2029.
   Web of Science ®Google Scholar
• Kaur J, Jacobs R, Huang Y, et al. Salivary biomarkers for oral cancer and pre-cancer screening: a review. Clin Oral Invest. 2018;22:633–640.
   PubMed Web of Science ®Google Scholar
• Li F, Yoshizawa JM, Kim KM, et al. Discovery and validation of salivary extracellular RNA biomarkers for noninvasive detection of gastric cancer. Clin Chem. 2018;64:1513–1521.
   PubMed Web of Science ®Google Scholar
• Whiting PF, Rutjes AWS, Westwood ME, et al. Quadas-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529–536.
   PubMed Web of Science ®Google Scholar
• Zamora J, Abraira V, Muriel A, et al. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol. 2006;6:31.
   PubMedGoogle Scholar
• Jones CM, Athanasiou T. Summary receiver operating characteristic curve analysis techniques in the evaluation of diagnostic tests. Ann Thoracic Surg. 2005;79:16–20.
   PubMed Web of Science ®Google Scholar
• Grimes DA, Schulz KF. Refining clinical diagnosis with likelihood ratios. Lancet. 2005;365:1500–1505.
   PubMed Web of Science ®Google Scholar
• Lijmer JG, Bossuyt PMM, Heisterkamp SH. Exploring sources of heterogeneity in systematic reviews of diagnostic tests. Statist Med. 2002;21:1525–1537.
   PubMed Web of Science ®Google Scholar
• Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol. 2005;58:882–893.
   PubMed Web of Science ®Google Scholar
• Brooks MN, Wang J, Li Y, et al. Salivary protein factors are elevated in breast cancer patients. Mol Med Report. 2008;1:375–378.
   PubMed Web of Science ®Google Scholar
• Chen DX, Schwartz PE, Li FQ. Saliva and serum CA 125 assays for detecting malignant ovarian tumors. Obstet Gynecol. 1990;75:701–704.
   PubMed Web of Science ®Google Scholar
• Cheng F, Wang Z, Huang Y, et al. Investigation of salivary free amino acid profile for early diagnosis of breast cancer with ultra performance liquid chromatography-mass spectrometry. Clin Chim Acta. 2015;447:23–31.
   PubMed Web of Science ®Google Scholar
• Farrell JJ, Zhang L, Zhou H, et al. Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer. Gut. 2012;61:582–588.
   PubMed Web of Science ®Google Scholar
• Humeau M, Vignolle-Vidoni A, Sicard F, et al. Salivary microRNA in pancreatic cancer patients. Plos One. 2015;10:e0130996.
   PubMed Web of Science ®Google Scholar
• Lee YH, Kim JH, Zhou H, et al. Salivary transcriptomic biomarkers for detection of ovarian cancer: for serous papillary adenocarcinoma. J Mol Med. 2012;90:427–434.
   PubMed Web of Science ®Google Scholar
• Li Y, Tan C, Liu L, et al. Significance of blood and salivary IEX-1 expression in diagnosis of epithelial ovarian carcinoma. J Obstet Gynaecol Res. 2018;44:764–771.
   PubMed Web of Science ®Google Scholar
• Liu X, Yu H, Qiao Y, et al. Salivary glycopatterns as potential biomarkers for screening of early-stage breast cancer. EBioMedicine. 2018;28:70–79.
   PubMed Web of Science ®Google Scholar
• Machida T, Tomofuji T, Maruyama T, et al. MiR 1246 and miR-4644 in salivary exosome as potential biomarkers for pancreatobiliary tract cancer. Oncol Rep. 2016;36:2375–2381.
   PubMed Web of Science ®Google Scholar
• Sazanov AA, Kiselyova EV, Zakharenko AA, et al. Plasma and saliva miR-21 expression in colorectal cancer patients. J Appl Genetics. 2017;58:231–237.
   PubMed Web of Science ®Google Scholar
• Shu J, Yu H, Li X, et al. Salivary glycopatterns as potential biomarkers for diagnosis of gastric cancer. Oncotarget. 2017;8:35718–35727.
   PubMedGoogle Scholar
• Streckfus C, Bigler L, Tucci M, et al. A preliminary study of CA15-3, c-erbB-2, epidermal growth factor receptor, cathepsin-D, and p53 in saliva among women with breast carcinoma. Cancer Invest. 2000;18:101–109.
   PubMed Web of Science ®Google Scholar
• Takayama T, Tsutsui H, Shimizu I, et al. Diagnostic approach to breast cancer patients based on target metabolomics in saliva by liquid chromatography with tandem mass spectrometry. Clin Chim Acta. 2016;452:18–26.
   PubMed Web of Science ®Google Scholar
• Wood N, Streckfus CF. The expression of lung resistance protein in saliva: a novel prognostic indicator protein for carcinoma of the breast. Cancer Invest. 2015;33:510–515.
   PubMed Web of Science ®Google Scholar
• Wu W, Hou W, Wu Z, et al. miRNA-144 in the saliva is a genetic marker for early diagnosis of esophageal cancer. Nan Fang Yi Ke Da Xue Xue Bao. 2013;33:1783–1786.
   PubMedGoogle Scholar
• Wu ZZ, Wang JG, Zhang XL. Diagnostic model of saliva protein finger print analysis of patients with gastric cancer. World J Gastroenterol. 2009;15:865–870.
   PubMed Web of Science ®Google Scholar
• Xiao H, Zhang L, Zhou H, et al. Proteomic analysis of human saliva from lung cancer patients using two-dimensional difference gel electrophoresis and mass spectrometry. Mol Cell Proteomics. 2012;11:M111.012112.
   PubMed Web of Science ®Google Scholar
• Xiao H, Zhang Y, Kim Y, et al. Differential proteomic analysis of human saliva using tandem mass tags quantification for gastric cancer detection. Sci Rep. 2016;6:22165.
   PubMed Web of Science ®Google Scholar
• Xie ZJ, Chen G, Zhang XC, et al. Saliva supernatant miR-21: a novel potential biomarker for esophageal cancer detection. Asian Pac J Cancer. 2012;13:6145–6149.
   PubMedGoogle Scholar
• Xie Z, Chen X, Li J, et al. Salivary HOTAIR and PVT1 as novel biomarkers for early pancreatic cancer. Oncotarget. 2016;7:25408–25419.
   PubMedGoogle Scholar
• Xie Z, Chen G, Zhang X, et al. Salivary microRNAs as promising biomarkers for detection of esophageal cancer. PloS One. 2013;8:e57502.
   PubMed Web of Science ®Google Scholar
• Xu YG, Cheng M, Zhang X, et al. Mutual information network-based support vector machine strategy identifies salivary biomarkers in gastric cancer. J BUON. 2017;22:119–125.
   PubMed Web of Science ®Google Scholar
• Yan X, Yang M, Liu J, et al. Discovery and validation of potential bacterial biomarkers for lung cancer. Am J Cancer Res. 2015;5:3111–3122.
   PubMed Web of Science ®Google Scholar
• Ye M, Ye P, Zhang W, et al. Diagnostic values of salivary versus and plasma microRNA-21 for early esophageal cancer. Nan Fang Yi Ke Da Xue Xue Bao. 2014;34:885–889.
   PubMedGoogle Scholar
• Zhang L, Farrell JJ, Zhou H, et al. Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer. Gastroenterology. 2010;138:949–957.e1-7.
   PubMed Web of Science ®Google Scholar
• Zhang L, Xiao H, Karlan S, et al. Discovery and preclinical validation of salivary transcriptomic and proteomic biomarkers for the non-invasive detection of breast cancer. PloS One. 2010;5:e15573.
   PubMed Web of Science ®Google Scholar
• Zhang L, Xiao H, Zhou H, et al. Development of transcriptomic biomarker signature in human saliva to detect lung cancer. Cell Mol Life Sci. 2012;69:3341–3350.
   PubMed Web of Science ®Google Scholar
• Zhong L, Cheng F, Lu X, et al. Untargeted saliva metabonomics study of breast cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations. Talanta. 2016;158:351–360.
   PubMed Web of Science ®Google Scholar
• Xie Z, Yin X, Gong B, et al. Salivary microRNAs show potential as a noninvasive biomarker for detecting resectable pancreatic cancer. Cancer Prev Res. 2015;8:165–173.
   PubMed Web of Science ®Google Scholar
• Kaczor-Urbanowicz KE, Martin Carreras-Presas C, Aro K, et al. Saliva diagnostics – current views and directions. Exp Biol Med. 2017;242:459–472.
   PubMed Web of Science ®Google Scholar
• Guerra ENS, Acevedo AC, Leite AF, et al. Diagnostic capability of salivary biomarkers in the assessment of head and neck cancer: a systematic review and meta-analysis. Oral Oncol. 2015;51:805–818.
   PubMed Web of Science ®Google Scholar
• Ding Y, Ma Q, Liu F, et al. The potential use of salivary miRNAs as promising biomarkers for detection of cancer: a meta-analysis. PLoS One. 2016;11:e0166303.
   PubMed Web of Science ®Google Scholar
• Baron JA. Screening for cancer with molecular markers: progress comes with potential problems. Nat Rev Cancer. 2012;12:368–371.
   PubMed Web of Science ®Google Scholar
• Fenton JJ, Weyrich MS, Durbin S, et al. Prostate-specific antigen-based screening for prostate cancer: evidence report and systematic review for the US Preventive services task force. JAMA. 2018;319:1914–1931.
   PubMed Web of Science ®Google Scholar
• Egger M, Smith GD, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634.
   PubMed Web of Science ®Google Scholar
• Wan JCM, Massie C, Garcia-Corbacho J, et al. Liquid biopsies come of age: towards implementation of circulating tumour DNA. Nat Rev Cancer. 2017;17:223–238.
   PubMed Web of Science ®Google Scholar
• Ding S, Song X, Geng X, et al. Saliva-derived cfDNA is applicable for EGFR mutation detection but not for quantitation analysis in non-small cell lung cancer. Thorac Cancer. 2019;10:1973–1983.
   PubMed Web of Science ®Google Scholar
• Pu D, Liang H, Wei F, et al. Evaluation of a novel saliva-based epidermal growth factor receptor mutation detection for lung cancer: a pilot study. Thoracic Cancer. 2016;7:428–436.
   PubMed Web of Science ®Google Scholar
• Wei F, Lin CC, Joon A, et al. Noninvasive saliva-based EGFR gene mutation detection in patients with lung cancer. Am J Respir Crit Care Med. 2014;190:1117–1126.
   PubMed Web of Science ®Google Scholar